tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE
US Market
RARE
Ultragenyx Pharmaceutical
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Ultragenyx Pharmaceutical (RARE) Stock News & Sentiment

Compare
807 Followers
Ultragenyx Pharmaceutical Approves Key Proposals at Annual Meeting
Premium
Company Announcements
Ultragenyx Pharmaceutical Approves Key Proposals at Annual Meeting
9d ago
8K
RARE
Optimistic Buy Rating for Ultragenyx: Strategic Developments and Favorable Regulatory Landscape Drive Growth Prospects
Premium
Ratings
Optimistic Buy Rating for Ultragenyx: Strategic Developments and Favorable Regulatory Landscape Drive Growth Prospects
19d ago
RARE
Ultragenyx Pharmaceutical: Promising Growth and Strategic Milestones Reinforce Buy Rating
Premium
Ratings
Ultragenyx Pharmaceutical: Promising Growth and Strategic Milestones Reinforce Buy Rating
20d ago
RARE
Ultragenyx Reports Strong Growth Amid Challenges
Premium
Company Announcements
Ultragenyx Reports Strong Growth Amid Challenges
20d ago
RARE
Ultragenyx Pharmaceutical: Strong Buy Rating Backed by Promising Pipeline and Consistent Demand
Premium
Ratings
Ultragenyx Pharmaceutical: Strong Buy Rating Backed by Promising Pipeline and Consistent Demand
21d ago
RARE
Ultragenyx Pharmaceutical: Undervalued Stock with Promising Pipeline and Strategic Entry Point
Premium
Ratings
Ultragenyx Pharmaceutical: Undervalued Stock with Promising Pipeline and Strategic Entry Point
21d ago
RARE
Buy Recommendation for Ultragenyx Pharmaceutical Driven by Strong Commercial Execution and Promising Pipeline
Premium
Ratings
Buy Recommendation for Ultragenyx Pharmaceutical Driven by Strong Commercial Execution and Promising Pipeline
21d ago
RARE
More RARE News >

RARE News on the Web

Evercore ISI Sticks to Its Buy Rating for Ultragenyx Pharmaceutical (RARE)
TipRanks News
Neutral
Decoding Ultragenyx Pharmaceutical Inc (RARE): A Strategic SWOT Insight
GuruFocus News
Neutral
Why Ultragenyx Pharmaceutical Inc.amp;#8217;s (RARE) Stock Is Up 7.51%
AAII
Neutral
Ultragenyx's Q1 Loss Wider Than Expected, Revenues Increase Y/Y
Zacks
Neutral
Investors will be rewarded for buying Ultragenyx at $35, says Citi
The Fly
Neutral
Ultragenyx Pharmaceutical Inc (RARE) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ...
GuruFocus News
Neutral
Q1 2025 Ultragenyx Pharmaceutical Inc Earnings Call Transcript
GuruFocus News
Neutral
Why Ultragenyx Pharmaceutical Inc.amp;#8217;s (RARE) Stock Is Down 5.22%
AAII
Neutral

News Score - Last 7 Days

Neutral
RARE
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RARE’s Media Buzz Sentiment?
Currently, no data Available
What is RARE’s weekly average amount of articles?
Currently, no data Available
What is RARE’s News Sentiment?
59% of articles about RARE were positive this week, compared to its sector average of 56%.
    Healthcare Stocks that are Trending in the News
    PAHCPhibro Animal Health
    PBHPrestige Consumer Healthcare
    HCSGHealthcare Services
    THCTenet Healthcare
    AJ91DocCheck AG
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing